Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Gynecologic Oncology

Breast Cancer

Multiple Myeloma

Lung Cancer

Immuno-Oncology News

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Gynecologic Oncology

Prolonging PFS With PARP Inhibitors in Platinum-Sensitive Ovarian Cancer

Alexander Olawaiye, MD, discusses the trials that led to the expanded approvals of PARP inhibitors as maintenance therapy in women with platinum-sensitive ovarian cancer.
Read More >>

Frontline Data for Newly Diagnosed Ovarian Cancer Leave Much to Be Discerned

Ovarian Cancer Researchers Continue to Push the Envelope

Recurrent Ovarian Cancer Paradigm Continues to Evolve

Immunotherapy Combo Strategies Are Major Research Focus in Ovarian Cancer

Questions Remain Across Treatment Modalities in Ovarian Cancer

View More Stories >>

View Conference Coverage

Charlotte Plasma Cell Disorder Congress

State of the Science Summit on Breast Cancer in Long Island

2019 International Lung Cancer Congress

2019 State of the Science Summit on Genitourinary Cancers in Jacksonville

2019 State of the Science Summit on Hematologic Malignancies in Pittsburgh

Dr. Moore on Unanswered Questions With PARP Inhibitors in Ovarian Cancer

Experts Discuss Highly Anticipated Study Results Across Tumor Types

Dr. Van Tine on Collaboration and Clinical Trials in Uterine Sarcoma

Dr. Cristea on Investigational Maintenance Strategies in Ovarian Cancer

Dr. Hong on the Mechanism of Action of Tisotumab vedotin in Cervical Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

PARP Inhibitor Mechanisms of Resistance

PARP Inhibitor Toxicity Management

Maintenance Therapy: PARP Inhibitor or Bevacizumab

Managing Platinum-Resistance and Recurrent Disease

Treatment Options for Patients with BRCA1/2

Targeted Therapy Options for Advanced Ovarian Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Directions in Advanced Ovarian Cancer Management

Genetic Counseling for Patients With Ovarian Cancer

Sequencing Antiangiogenic Agents in Advanced Ovarian Cancer

Sequencing PARP Inhibitors in Advanced Ovarian Cancer

Prepping Patients With Advanced OC for PARP Inhibition

Management of PARP Inhibitor AEs in Ovarian Cancer

Impact of SOLO-1 on Advanced Ovarian Cancer Management

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Emerging Concepts-Advanced Ovarian, Fallopian, Peritoneal, and Cervical Cancers

This discussion, led by James Tate Thigpen, MD, features the most recent information pertaining to treatment of gynecologic malignancies. The expert panel, Robert L. Coleman, MD, FACOG, FACS; Thomas Herzog, MD; Bradley J. Monk, MD, FACOG, FACS; and Angeles Alvarez Secord, MD, review the research and how to apply it in practice.View Now

Challenges for the Future of Gynecologic Cancers

Panelists provide their perspectives on the key challenges facing the future of ovarian and cervical cancer treatment.View Now

Featured Video

Dr. Richardson Discusses New Directions in Multiple Myeloma

Paul G. Richardson, MD, clinical program leader and director of clinical research, Jerome Lipper Multiple Myeloma Center, and institute physician, Dana-Farber Cancer Institute, discusses new directions in multiple myeloma. View now

Priority Review Designation in GIST, Promising Findings in Bladder Cancer and NSCLC, and More